United States Sexually Transmitted Disease (STD ) Drug Market Report 2018

In this report, the United States Sexually Transmitted Disease (STD ) Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Sexually Transmitted Disease (STD ) Drug in these regions, from 2013 to 2025 (forecast).

United States Sexually Transmitted Disease (STD ) Drug market competition by top manufacturers/players, with Sexually Transmitted Disease (STD ) Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Pfizer

Roche

Bayer

Eli Lilly

Johnson & Johnson

Bristol-Myers Squibb

AbbVie

Gilead Sciences

GlaxoSmithKline

Merck

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Antibiotics

Antiviral

Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospital

Clinic

Research Methodology

In spite of political and economic instability in the recent past, pharmaceutical and healthcare industry is booming across the globe. Cutting edge technology in medical devices, reformation in biotech & pharmaceuticals, and remarkable growth in the geriatric population are some of the important reasons behind rapidly flourishing healthcare and pharmaceutical industry.

QY Research has offered a comprehensive assessment of the markets in the pharmaceutical & healthcare industry in its recently published research report. This evaluation is done on the basis of historical data, quantitative & qualitative insights and flexible projections about the size of the market. As per the requirement of pharmaceutical and healthcare industry, various techniques are used on an experimental basis to make this report an exclusive one. These techniques are patient-level data, insights on medical technology & devices and comprehensive data on a number of procedures.

Strategies of top players in the pharmaceutical and healthcare industry

QY Research has provided thorough information from vendors along with a complete analysis of the performance of leading players across the globe operating in the pharmaceutical and healthcare industry. One of the important aspects covered in this report is an in-depth evaluation of various markets fall under the purview of the pharmaceutical and healthcare industry and its growth prospects in the years to come. This research report has also included the ideas exchanged between analysts and key players functioning in the industry. 

QY Research has also offered an easily navigable platform which will help clients in assessing their as well as their competitive vendors’ value. This unique feature provided by QY Research would not only help top players in the market in placing their strategies but will also guide them in successfully achieving their targets in the extremely competitive market.

Analysis of market taxonomy   

The markets covered under the purview of the pharmaceutical and healthcare sector are generally segmented as, by product, by application, by end user and by region. QY Research has given emphasis on providing segmental analysis in a comprehensive way for the better understanding of the overall market. To effectively gather market values, weighted average selling prices have been taken into consideration on the basis of products.

Further, to make this report detail and wide-ranging QY Research has used a top-down approach to evaluate market numbers for almost every category of products. On the other hand, to counter validate all the market estimations, bottom-up approach has been used by the experts in pharmaceutical and healthcare sector. While examining different segments of the markets in the pharmaceutical and healthcare industry, the analysts in QY Research have carried out several surveys along with detailed primary research.

Regional Analysis

This research report has presented various market segments with an in-depth analysis of key regions. Based on the regions the market is classified into the Middle East and Africa, Eastern & Western Europe, Latin America, the Asia Pacific including Japan and North America. The regional splits of the entire market along with its sub-segments are based on the use of the particular product in the respective regions or countries.

The research analysts in QY Research went the extra mile to provide detail information about the scope of industries in countries such as the United States, Brazil, China, Japan, Malaysia, India and South Korea. There is a huge demand for dietary supplements, veterinary drugs, medicines, human and veterinary vaccines, and blood products across the globe.

North America and Europe region, in particular, have witnessed a large demand for these products because of growing disposable income and thereby improving lifestyle. Due to increasing demands for the pharmaceutical and healthcare products, Gross Domestic Product of the regions and countries has increased and it has led to the market revenue which turns into an increase in the economy of the countries.

Lucid and coherent research reports are the forte of QY Research

For easy and better understanding and organization of the report, experts have classified the report based on the pharmaceutical and healthcare sector in three parts. The first part of the research report consists of an overview of the report which is generally known as the introduction section. This section contains a market viewpoint and in-depth information about the concerned product. 

The second part of the report includes market dynamics such as trends, drivers, restraints and various opportunities. Comprehensive information about pricing analysis is also a part of this section. Regional analysis is provided in the third part of the report.

One of its kind research methodology

The dedicated team of analysts have initially conducted primary research that include various demand-side users such as surgeons, chief opinion leaders, and physicians, while the participants from supply-side providers of various medical devices have offered valuable inputs on patient education, competitive dynamics and pricing, manufacturers and their significant strategies and development of medical devices.

To recognize the viability of the target category of technologies or products and its respective product offerings, segments, the lifespan of various medical devices and to target various healthcare facilities, QY Research has carried out secondary research. Thus each and every piece of information is gradually evaluated over the course of a research project that builds a solid base for secondary as well as primary research.

It is to be noted that these are just initial steps that are being followed by the research team of QY Research. Apart from this, to make this report an exclusive one analysts have done the forecasting based on internal methodology and models developed in QY Research that uses various macro-economic factors such as per capita income and healthcare expenditure.

QY Research, offers detail analysis, research, forecasts and data through the team of market analysts, consultants and industry experts in the process, ensuring the reliability of information through a multi-check audit process. QY Research provides advanced industry-specific models that are used in order to ensure accuracy and completeness of data

List of Tables and Figures

Figure Product Picture of Sexually Transmitted Disease (STD ) Drug

Figure United States Sexually Transmitted Disease (STD ) Drug Market Size (K Units) by Type (2013-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Volume Market Share by Type (Product Category) in 2017

Figure Antibiotics Product Picture

Figure Antiviral Product Picture

Figure Vaccines Product Picture

Figure United States Sexually Transmitted Disease (STD ) Drug Market Size (K Units) by Application (2013-2025)

Figure United States Sales Market Share of Sexually Transmitted Disease (STD ) Drug by Application in 2017

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure United States Sexually Transmitted Disease (STD ) Drug Market Size (Million USD) by Region (2013-2025)

Figure The West Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southwest Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Middle Atlantic Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure New England Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure The South of US Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Midwest Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales (K Units) and Growth Rate (2013-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Market Major Players Product Sales Volume (K Units) (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Sales (K Units) of Key Players/Suppliers (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Sales Share by Players/Suppliers (2013-2018)

Figure 2017 United States Sexually Transmitted Disease (STD ) Drug Sales Share by Players/Suppliers

Figure 2017 United States Sexually Transmitted Disease (STD ) Drug Sales Share by Players/Suppliers

Figure United States Sexually Transmitted Disease (STD ) Drug Market Major Players Product Revenue (Million USD) (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) by Players/Suppliers (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 United States Sexually Transmitted Disease (STD ) Drug Revenue Share by Players/Suppliers

Figure 2017 United States Sexually Transmitted Disease (STD ) Drug Revenue Share by Players/Suppliers

Table United States Market Sexually Transmitted Disease (STD ) Drug Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)

Figure United States Market Sexually Transmitted Disease (STD ) Drug Average Price (USD/Unit) of Key Players/Suppliers in 2017

Figure United States Sexually Transmitted Disease (STD ) Drug Market Share of Top 3 Players/Suppliers

Figure United States Sexually Transmitted Disease (STD ) Drug Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Sexually Transmitted Disease (STD ) Drug Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Sexually Transmitted Disease (STD ) Drug Product Category

Table United States Sexually Transmitted Disease (STD ) Drug Sales (K Units) by Region (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Sales Share by Region (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Share by Region (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region in 2017

Table United States Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Market Share by Region (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Revenue Share by Region (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region in 2017

Table United States Sexually Transmitted Disease (STD ) Drug Price (USD/Unit) by Region (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Sales (K Units) by Type (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Sales Share by Type (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Share by Type (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type in 2017

Table United States Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Market Share by Type (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Sexually Transmitted Disease (STD ) Drug by Type (2013-2018)

Figure Revenue Market Share of Sexually Transmitted Disease (STD ) Drug by Type in 2017

Table United States Sexually Transmitted Disease (STD ) Drug Price (USD/Unit) by Types (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Growth Rate by Type (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Sales (K Units) by Application (2013-2018)

Table United States Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application in 2017

Table United States Sexually Transmitted Disease (STD ) Drug Sales Growth Rate by Application (2013-2018)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Growth Rate by Application (2013-2018)

Table Pfizer Basic Information List

Table Pfizer Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure Pfizer Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure Pfizer Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table Roche Basic Information List

Table Roche Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Roche Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure Roche Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure Roche Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table Bayer Basic Information List

Table Bayer Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Bayer Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure Bayer Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure Bayer Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table Eli Lilly Basic Information List

Table Eli Lilly Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Eli Lilly Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure Eli Lilly Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure Eli Lilly Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table AbbVie Basic Information List

Table AbbVie Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure AbbVie Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure AbbVie Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure AbbVie Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table Gilead Sciences Basic Information List

Table Gilead Sciences Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Gilead Sciences Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure Gilead Sciences Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure Gilead Sciences Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table Merck Basic Information List

Table Merck Sexually Transmitted Disease (STD ) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Merck Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2013-2018)

Figure Merck Sexually Transmitted Disease (STD ) Drug Sales Market Share in United States (2013-2018)

Figure Merck Sexually Transmitted Disease (STD ) Drug Revenue Market Share in United States (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Sexually Transmitted Disease (STD ) Drug

Figure Manufacturing Process Analysis of Sexually Transmitted Disease (STD ) Drug

Figure Sexually Transmitted Disease (STD ) Drug Industrial Chain Analysis

Table Raw Materials Sources of Sexually Transmitted Disease (STD ) Drug Major Players/Suppliers in 2017

Table Major Buyers of Sexually Transmitted Disease (STD ) Drug

Table Distributors/Traders List

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Price (USD/Unit) Trend Forecast (2018-2025)

Table United States Sexually Transmitted Disease (STD ) Drug Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Volume (K Units) Forecast by Type in 2025

Table United States Sexually Transmitted Disease (STD ) Drug Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Volume (K Units) Forecast by Application in 2025

Table United States Sexually Transmitted Disease (STD ) Drug Sales Volume (K Units) Forecast by Region (2018-2025)

Table United States Sexually Transmitted Disease (STD ) Drug Sales Volume Share Forecast by Region (2018-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Volume Share Forecast by Region (2018-2025)

Figure United States Sexually Transmitted Disease (STD ) Drug Sales Volume Share Forecast by Region in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources